ANIX News and Press, Anixa Biosciences Inc. From 01/23/24

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology PR Newswire Broad coverage extended to Japan and related regions SAN JOSE, Calif. , Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or t...

NEW YORK, NY / ACCESSWIRE / January 16, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 17-18, 2024. The presentation schedule is su...

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024 PR Newswire SAN JOSE, Calif. , Jan. 10, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology co...

Anixa Biosciences Inc. (ANIX) is expected to report $-0.09 for Q4 2023 Eaco Corp. (EACO) is expected to report for Q2 2024 Rite Aid Corporation. (RADCQ) is expected to report $-1.45 for Q3 2024 KB Home (KBH) is expected to report $1.67 for Q4 2023 Dogness (International) Corporati...

Anixa Biosciences Inc. (ANIX) is expected to report $-0.09 for Q4 2023

Anixa Biosciences to Present at Biotech Showcase 2024 PR Newswire SAN JOSE, Calif. , Dec. 14, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and...

2023-12-11 12:26:14 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some of the most explosive opportunities can be found in biotech stocks. Look at CRISPR Therapeutics (NASDAQ: CRSP ), for example. Leading up to U.S. FDA rulings, the st...

2023-12-08 18:24:17 ET Summary Anixa Biosciences is a biotech specializing in immunotherapy treatments for breast and ovarian cancers. They are developing a vaccine for α-lactalbumin in triple-negative breast cancer and AMHR2 in ovarian cancer. ANIX is also involved in ...

2023-12-07 06:50:16 ET More on Anixa Biosciences Seeking Alpha’s Quant Rating on Anixa Biosciences Historical earnings data for Anixa Biosciences Financial information for Anixa Bioscience 8 For further details see: Anixa Bio falls after Phase 1 da...

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine PR Newswire – Antigen-specific T cell responses were observed at all dose levels – – IFNγ and IL-17, immune-mediated biomarkers of T...